iShares Biotechnology ETF $IBB Shares Sold by Principle Wealth Partners LLC

Principle Wealth Partners LLC lessened its position in iShares Biotechnology ETF (NASDAQ:IBB) by 1.5% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 5,081 shares of the financial services provider’s stock after selling 79 shares during the period. Principle Wealth Partners LLC’s holdings in iShares Biotechnology ETF were worth $643,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Moors & Cabot Inc. lifted its stake in shares of iShares Biotechnology ETF by 2.0% in the 1st quarter. Moors & Cabot Inc. now owns 29,053 shares of the financial services provider’s stock worth $3,716,000 after acquiring an additional 558 shares during the period. IFP Advisors Inc lifted its stake in shares of iShares Biotechnology ETF by 23.9% in the 1st quarter. IFP Advisors Inc now owns 19,849 shares of the financial services provider’s stock worth $2,539,000 after acquiring an additional 3,831 shares during the period. N.E.W. Advisory Services LLC acquired a new stake in shares of iShares Biotechnology ETF in the 1st quarter worth $45,000. John G Ullman & Associates Inc. acquired a new stake in shares of iShares Biotechnology ETF in the 1st quarter worth $230,000. Finally, KFG Wealth Management LLC lifted its stake in shares of iShares Biotechnology ETF by 4.8% in the 2nd quarter. KFG Wealth Management LLC now owns 2,444 shares of the financial services provider’s stock worth $309,000 after acquiring an additional 112 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB stock opened at $154.58 on Friday. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $157.19. The company has a fifty day moving average of $144.55 and a 200-day moving average of $132.35.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were paid a $0.0828 dividend. This represents a $0.33 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.